A comparison of 4β-hydroxycholesterol : cholesterol and 6β-hydroxycortisol : cortisol as markers of CYP3A4 induction. 2013

Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
Clinical Chemistry, Karolinska University Hospital, Huddinge, Sweden.

OBJECTIVE To compare plasma 4β-hydroxycholesterol : cholesterol with urinary 6β-hydroxycortisol : cortisol as markers of cytochrome P4503A4 activity before and after treatment with rifampicin for 2 weeks. METHODS 6β-hydroxycortisol and cortisol were determined by liquid chromatography tandem mass spectrometry and 4β-hydroxycholesterol was determined by gas chromatography-mass spectrometry in three groups of healthy volunteers. RESULTS Induction ratios for 6β-hydroxycortisol : cortisol were 1.8, 3.9 and 4.5 for 20 mg day(-1) , 100 mg day(-1) or 500 mg day(-1) of rifampicin, respectively. The corresponding ratios for 4β-hydroxycholesterol : cholesterol were 1.5, 2.4 and 3.8. CONCLUSIONS Plasma 4β-hydroxycholesterol : cholesterol gave similar induction ratios to urinary 6β-hydroxycortisol : cortisol.

UI MeSH Term Description Entries
D008297 Male Males
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D006888 Hydroxycholesterols Cholesterol which is substituted by a hydroxy group in any position.
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
August 2013, Drug metabolism and disposition: the biological fate of chemicals,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
August 2018, Therapeutic drug monitoring,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
April 2015, Journal of chromatographic science,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
January 2014, Drug metabolism and pharmacokinetics,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
December 2021, Journal of mass spectrometry : JMS,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
April 2018, The AAPS journal,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
June 2011, Clinical pharmacology and therapeutics,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
February 2011, British journal of clinical pharmacology,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
April 2024, British journal of clinical pharmacology,
Yvonne Mårde Arrhén, and Hanna Nylén, and Anita Lövgren-Sandblom, and Kajsa P Kanebratt, and Katarina Wide, and Ulf Diczfalusy
July 2018, British journal of clinical pharmacology,
Copied contents to your clipboard!